Ziad Bakouny

9.2k citations
111 papers · 1.6k indexed · 1 hit paper · h-index 20

Ziad Bakouny

100 papers receiving 1.6k citations

Hit Papers

Beyond conventional immune-checkpoint inhibition — novel ...224202120262022202450100150200

Peers

Ziad Bakouny
Comparison fields: 5 of 104
  • Oncology 761
  • Pulmonary and Respiratory Medicine 791
  • Cancer Research 324
  • Health Informatics 14
  • Surgery 372
Replace Deniz Can Güven with:
Deniz Can Güven Türkiye
Rajen Mody United States
Valentina I. Petkov United States
Marwan Ghosn Lebanon
G. Pignot France
David Watkins United Kingdom
Hampig Raphaël Kourié Lebanon
Cheng‐Maw Ho Taiwan
Beodeul Kang South Korea
Cheuk‐Wai Choi Hong Kong
Ziad Bakouny relative to Deniz Can Güven Türkiye Deniz Can Güven's profile →
Citations per field
00.5×4.6×
Deniz Can Güven · 1×
Citations per year

Countries citing papers authored by Ziad Bakouny

Since Specialization
Citations

This map shows the geographic impact of Ziad Bakouny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziad Bakouny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziad Bakouny more than expected).

Fields of papers citing papers by Ziad Bakouny

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ziad Bakouny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziad Bakouny. The network helps show where Ziad Bakouny may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ziad Bakouny, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ziad Bakouny Line = papers co-authored together Ziad Bakouny links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20240
2 20244
3 20236
4 20231
5 202313
6 20223
7 202217
8 202133
9 20204
10 2020169
11 202015
12 202042
13 20203
14 202013
15 201948
16 20195
17 20180
18 201820
19 201817
20 201620

About Ziad Bakouny

Ziad Bakouny is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 111 papers that have together received 1.6k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (44 papers), Cancer Genomics and Diagnostics (23 papers), Cancer Immunotherapy and Biomarkers (20 papers), Scoliosis diagnosis and treatment (15 papers), Renal and related cancers (14 papers), Bladder and Urothelial Cancer Treatments (11 papers), Spinal Fractures and Fixation Techniques (10 papers) and Hip disorders and treatments (8 papers). The work is most often cited by research in Oncology (761 citations), Pulmonary and Respiratory Medicine (791 citations) and Cancer Research (324 citations). Ziad Bakouny has collaborated with scholars based in United States, Lebanon and France. Frequent co-authors include Toni K. Choueiri, David A. Braun, Eliezer M. Van Allen, Ronan Flippot, Laure Hirsch, Catherine J. Wu, Ayman Assi, Brian I. Rini, Solange Peters and Ismat Ghanem. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026